A highly conserved molecular switch binds MSY-3 to regulate myogenin repression in postnatal muscle

Abstract

Myogenin is the dominant transcriptional regulator of embryonic and fetal muscle differentiation and during maturation is profoundly down-regulated. We show that a highly conserved 17-bp DNA cis-acting sequence element located upstream of the myogenin promoter (myogHCE) is essential for postnatal repression of myogenin in transgenic animals. We present multiple lines of evidence supporting the idea that repression is mediated by the Y-box protein MSY-3. Electroporation in vivo shows that myogHCE and MSY-3 are required for postnatal repression. We further show that, in the C2C12 cell culture system, ectopic MSY-3 can repress differentiation, while reduced MSY-3 promotes premature differentiation. MSY-3 binds myogHCE simultaneously with the homeodomain protein Pbx in postnatal innervated muscle. We therefore propose a model in which the myogHCE motif operates as a switch by specifying opposing functions; one that was shown previously is regulated by MyoD and Pbx and it specifies a chromatin opening, gene-activating function at the time myoblasts begin to differentiate; the other includes MYS-3 and Pbx, and it specifies a repression function that operates during and after postnatal muscle maturation in vivo and in myoblasts before they begin to differentiate.[Keywords: CsdA; MSY-3; myogenin; Y-box; innervation; muscle maturation] Supplemental material is available at http://www.genesdev.org.

miR-186 Inhibits Muscle Cell Differentiation through Myogenin Regulation

“…Transfections using a negative control (negative miRNA) were carried out in parallel. Scale bar, 200 m. (19,46,47). Following screening for possible targets of miR-186 at the proliferative stage, we decided to select mouse cyclin-D1 as it is also expressed both in the pathway of interest and at the specific stage of interest.…”

A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice

“…Vectors used were mouse TGFβ2 (ATCC, MGC-18603), E[beta]C (28) (Addgene), pLVX-EF1alpha-IRES-mCherry (Clontech), nGFP (90), B9L, and B9LDCter (29). Two days after transfection, cells were trypsinized and purified according to mCherry expression by FACS.…”

Histone Methyltransferase KMT1A Restrains Entry of Alveolar Rhabdomyosarcoma Cells into a Myogenic Differentiated State

“…Here, we show that KMT1A knock-down arrests proliferation and induces terminal differentiation of ARMS cells. Furthermore, KMT1A down-modulation restores MyoD transcriptional activation, including the induction of myogenin required for terminal differentiation (8, 23, 24). Finally, we demonstrate that KMT1A-depleted ARMS cells are incapable of forming tumors in mice.…”